Status | Study |
Recruiting |
Study Name: Irisin Hormone Levels in Endometrial Hyperplasia Condition: Endometrial Hyperplasia Date: 2016-09-13 |
Recruiting |
Study Name: Study Into Treatment of Hyperplasia of Mammary Glands Condition: Hyperplasia Date: 2015-07-18 Interventions: Other: No intervention |
Recruiting |
Study Name: Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams Condition: Prostatic Hyperplasia Date: 2015-03-12 Interventions: Device: Embosphere Microspheres |
Recruiting |
Study Name: Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia Condition: Benign Prostatic Hyperplasia Date: 2014-07-29 Interventions: Drug: Embozene Microspheres Intraarterial application |
Completed |
Study Name: Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH) Condition: Benign Prostatic Hyperplasia Date: 2014-06-17 Interventions: Device: Microspheres Prostatic artery embolization (PAE) is a new procedure that decreases the size of t |
Completed |
Study Name: Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia Condition: Prostatic Hyperplasia Date: 2014-01-23 Interventions: Drug: Dutasteride 0.5mg capsules |
Recruiting |
Study Name: Prostate Embolization for Benign Prostatic Hyperplasia Condition: Benign Prostatic Hyperplasia Date: 2013-08-14 Interventions: Procedure: Prostatic Embolization |
Completed |
Study Name: Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia Condition: Benign Prostatic Hyperplasia Date: 2012-12-21 Interventions: Drug: Silodosin 8 mg daily for 24 weeks |
Terminated |
Study Name: Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia Condition: Prostatic Hyperplasia Date: 2012-06-28 Interventions: Drug: Dutasteride/Tamsulosin 0.5 mg dutasteride/ 0.4 mg tamsulosin once daily for the duration of 180 da |
Completed |
Study Name: Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women Condition: Endometrial Hyperplasia Date: 2011-12-20 Interventions: Drug: LNG-IUS; Mirena; Bayer Schering Pharma Oy, Finland |